ANIP
ANI Pharmaceuticals Inc
74.00$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,471.5% | -178,782,200.0% | -160,380,200.0% | -104.4% | -139.8% | -8,431.3% | -13,407.3% | -3,211.7% | -34.6% | 150.1% | -410.9% | -1,465.0% | -1,620.6% | -11,000.6% | -1,098.9% | -18.2% | 39.4% | 22.6% | 21.4% | 22.3% | 33.3% | 22.1% | 7.3% | 1.5% | -9.9% | 24.4% | 10.4% | 21.0% | |
| 113.6% | 9,096,500.0% | 6,139,500.0% | 6.3% | 3.2% | 141.9% | 130.9% | 39.1% | 0.8% | 18.2% | 1.1% | 10.9% | 6.8% | 34.1% | 11.3% | 3.7% | 6.9% | 9.0% | 17.4% | 15.8% | 16.7% | 21.6% | 21.4% | 21.9% | 18.9% | 12.3% | 11.0% | 10.3% | |
| – | – | – | 1.0% | 0.6% | 294.7% | 735.1% | 136,055.2% | – | – | 29.2% | 99.7% | 40.1% | 270.6% | 31.5% | 14.8% | 6.1% | 5.1% | 4.7% | 3.4% | 3.4% | 4.5% | 6.2% | 4.9% | 4.6% | 4.2% | 4.8% | 4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 402.2% | 265.2% | 0.2% | -18.7% | 2.6% | 3.0% | 6.0% | 1.7% | 1.2% | 1.9% | -1.7% | 0.1% | – | – | – | |
| -529.6% | -47,252,800.0% | 5,340,050.0% | 31.6% | -8.6% | 231.2% | 1,154.6% | 58.5% | -62.2% | 1,543.2% | 16.9% | -125.5% | 112.2% | 417.4% | -170.6% | -37.8% | -0.2% | -18.2% | -7.7% | -3.2% | 3.0% | -7.1% | -6.1% | 0.0% | -16.2% | 5.1% | -1.8% | -0.8% | |
| 101.6% | 421,900.0% | 2,161,900.0% | 5.0% | 1.4% | 13.5% | 132.5% | 26.1% | 0.3% | 6.0% | 17.2% | 13.2% | 2.6% | 165.4% | 26.6% | 0.6% | 63.9% | 42.8% | 115.9% | 61.1% | 5.4% | 13.3% | 32.8% | 10.9% | 5.2% | 3.8% | 2.8% | 3.9% | |
| -101.6% | -421,900.0% | -2,161,900.0% | -5.0% | -1.4% | -13.5% | -20,802.0% | 2,802.5% | 34.3% | -2,279.6% | 299.6% | 227.4% | -2.4% | -165.4% | -26.9% | 67.4% | -63.9% | -42.8% | -119.8% | -61.1% | -13.6% | -13.3% | -32.8% | -48.8% | -5.0% | -3.8% | -65.9% | -3.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 2.8% | 0.3% | 0.1% | 0.5% | 0.3% | 0.3% | 0.1% | |
| – | – | -600.0% | – | -0.1% | – | – | – | – | – | – | – | – | 5,499.8% | 0.0% | -1.4% | 58.3% | -0.1% | -2.0% | -0.1% | -0.3% | -0.5% | -0.7% | -0.4% | -0.6% | -1.0% | -1.8% | -1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13.5% | 247.0% | 98.3% | -0.2% | 40.9% | -14.4% | -58.8% | -0.3% | 45.8% | -0.9% | -0.6% | 56.2% | -1.1% | |
| 3,459.5% | 422,534,300.0% | 29,402,250.0% | 217.5% | 154.7% | 14,934.9% | 23,983.8% | 76.6% | 51.1% | 3,751.0% | 8.4% | 2,676.2% | 1,958.4% | 15,548.3% | 150.9% | -12.3% | 306.7% | 1.4% | -0.6% | 40.9% | -13.8% | 0.6% | -0.7% | 90.0% | -1.6% | 13.9% | 43.1% | -1.1% | |
| 886.5% | 243,330,200.0% | -133,139,850.0% | 108.2% | 13.5% | 6,490.1% | -10,225.6% | -332.6% | 50.9% | 1,621.5% | -102.8% | 1,438.5% | 335.3% | 4,382.3% | -974.9% | 36.9% | 282.2% | -18.8% | -99.0% | 2.1% | 5.9% | 9.4% | -26.1% | 42.8% | -16.5% | 34.5% | -12.4% | 15.9% | |
| -2,573.0% | -179,204,100.0% | -162,542,100.0% | -109.3% | -141.2% | -8,444.8% | -13,539.8% | -3,237.8% | -34.9% | 144.1% | -428.1% | -1,478.2% | -1,623.2% | -11,166.0% | -1,125.5% | -18.9% | -24.5% | -20.2% | -94.5% | -38.8% | 27.9% | 8.8% | -25.4% | -9.4% | -15.1% | 20.6% | 7.7% | 17.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.